Our team at Aptitude is proud to be delivering on our promise to democratize diagnostics - our Metrix platform empowers patients as participants in healthcare, enabling anyone to wield the power of a lab-quality molecular diagnostic in their hands, and do it for less than the cost of a copay. We have been personally moved to hear from so many users for whom our humble Metrix COVID-19 test has made a meaningful difference by enabling them to gain the most reliable test results at a dramatically more accessible price point than any other option on the market.
The need for dramatically more accessible high quality molecular testing is just as pervasive in professional settings where complex instruments and onerous purchase contracts have blocked practices from giving the highest quality care to their patients.
Today, we are thrilled to announce our partnership with Sekisui Diagnostics to increase the commercial reach of Metrix so healthcare professionals in urgent care or long-term care facilities, physician offices, and pharmacies no longer need to choose between accuracy and economic viability - with Metrix they can have both, enabling uncompromising value with molecular testing anywhere and everywhere.